MIDATECH PHARMA
Investors | Shareholder information
Shareholder Meeting Notices
Date Title Document Webcast
11/04/2017 Notice of Annual General Meeting 2017
12/10/2016 Notice of General Meeting to be held on 28 October 2016
11/05/2016 Notice of 2016 AGM
21/05/2015 Notice of 2015 AGM
Share Detail
Number of shares 48,719,456
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP

The percentage of 0.005p Ordinary shares not being held in public hands is 61.2%

Shares held in treasury: Nil 0.005p Ordinary shares.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 15 March 2017

Major shareholders
Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.
Name Number of shares %
Woodford Investment Management 9,867,629 20.3
Legal & General Group

6,275,518

12.9
Ferracom Establishment 3,043,164 6.2
Hargreave Hale 2,988,055 6.1
City Financial 2,150,000 4.4
Ippon Capital SA 1,649,334 3.4
N+1 Singer 1,521,794 3.1
     
Midatech Pharma Share Incentive Plan 24,449 n/a

Information correct as at 30 May 2017

ADR Information
Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 2 Ordinary Shares US59564R1041 59564R104
Investors
Shareholder information
© Copyright 2017 Midatech Pharma PLC